Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP

Matthias Pauschinger1, Kumaran Chandrasekharan, Heinz-Peter Schultheiss

  • 1Department of Cardiology, University Hospital Benjamin Franklin, Free University Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany. pauschinger@ukbf.fu-berlin.de

Heart Failure Reviews
|January 24, 2004
PubMed

Insights

Inflammation in viral myocarditis alters the balance of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). This imbalance contributes to cardiac remodeling and the progression to dilated cardiomyopathy.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Pathophysiology

Background:

  • Matrix metalloproteinases (MMPs) degrade extracellular matrix, influencing cardiac interstitial architecture.
  • MMPs and their inhibitors (TIMPs) are crucial for maintaining myocardial homeostasis; their imbalance is implicated in heart failure.
  • Cytokines and inflammation, particularly in viral myocarditis, can disrupt the MMP-TIMP system and contribute to cardiac remodeling.

Purpose of the Study:

  • To review the inflammatory phase in viral myocarditis.
  • To explore the interplay between inflammation and myocardial MMP profiles.
  • To elucidate the mechanisms leading to dilated cardiomyopathy.

Main Methods:

  • Literature review of viral myocarditis and cardiac remodeling.
  • Analysis of the role of MMPs and TIMPs in myocardial inflammation.
  • Examination of cytokine-mediated effects on the MMP-TIMP system.

Main Results:

  • Viral infections trigger intramyocardial inflammation, a key factor in disease progression.
  • Inflammatory cells and cytokines in viral myocarditis can dysregulate the myocardial MMP-TIMP system.
  • Alterations in the MMP-TIMP system are linked to cardiac dilation and ventricular dysfunction.

Conclusions:

  • Inflammation is a critical determinant in the progression of viral myocarditis to dilated cardiomyopathy.
  • The MMP-TIMP system is a key mediator linking inflammation to cardiac remodeling.
  • Understanding these interactions may reveal therapeutic targets for preventing dilated cardiomyopathy.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...